Abuse-deterring technology developer Egalet nets $53.9mm in IPO
- Controlled Release
- Drug Delivery
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.